HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fabrizio Stocchi Selected Research

safinamide

2/2022Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus.
1/2021The Current Evidence for the Use of Safinamide for the Treatment of Parkinson's Disease.
1/2016Adjuvant therapies for Parkinson's disease: critical evaluation of safinamide.
9/2014Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease.
1/2012A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fabrizio Stocchi Research Topics

Disease

90Parkinson Disease (Parkinson's Disease)
09/2022 - 09/2002
31Dyskinesias (Dyskinesia)
06/2021 - 09/2002
6Fatigue
02/2022 - 05/2011
4Dementia (Dementias)
01/2022 - 01/2019
4Disease Progression
10/2016 - 01/2003
3Deglutition Disorders (Dysphagia)
03/2022 - 12/2009
3Pain (Aches)
02/2022 - 01/2017
3Constipation
02/2022 - 12/2015
3Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2020
3Tremor (Tremors)
01/2021 - 11/2012
3Sleep Initiation and Maintenance Disorders (Insomnia)
11/2020 - 11/2013
3Cognitive Dysfunction
01/2019 - 06/2012
2Major Depressive Disorder (Major Depressive Disorders)
01/2021 - 11/2012
2Parkinsonian Disorders (Parkinsonism)
06/2015 - 12/2009
2Hallucinations (Hallucination)
11/2013 - 03/2003
1Movement Disorders (Movement Disorder)
02/2022
1Tauopathies
01/2022
1Injection Site Reaction
11/2021
1Seizures (Absence Seizure)
01/2021
1Orthostatic Hypotension (Postural Hypotension)
09/2020
1Psychotic Disorders (Schizoaffective Disorder)
09/2020
1Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
09/2020
1REM Sleep Behavior Disorder
09/2020
1Heart Failure
09/2020
1Disorders of Excessive Somnolence (Hypersomnia)
09/2020
1Nocturia
03/2020
1Back Pain (Backache)
01/2020
1Inflammation (Inflammations)
01/2020
1Prodromal Symptoms
01/2019
1Ataxia (Dyssynergia)
01/2017
1Nausea
01/2016
1Fibrosis (Cirrhosis)
06/2015
1Confusion (Bewilderment)
12/2014
1Sleep Wake Disorders
07/2014
1Dizziness (Lightheadedness)
11/2013
1Diarrhea
11/2013
1Nasopharyngitis
11/2013
1Body Weight (Weight, Body)
07/2013

Drug/Important Bio-Agent (IBA)

49Levodopa (L Dopa)FDA LinkGeneric
09/2022 - 09/2002
13Pharmaceutical PreparationsIBA
01/2022 - 01/2003
12Carbidopa (Lodosyn)FDA LinkGeneric
11/2021 - 06/2005
11Dopamine Agonists (Dopamine Agonist)IBA
09/2020 - 07/2003
6levodopa methyl esterIBA
12/2019 - 01/2007
6rasagiline (Azilect)FDA Link
10/2016 - 11/2008
5safinamideIBA
02/2022 - 01/2012
5Dopamine Receptors (Dopamine Receptor)IBA
05/2011 - 07/2006
4opicaponeIBA
09/2022 - 07/2017
4Dopamine (Intropin)FDA LinkGeneric
09/2020 - 07/2010
4ropinirole (Requip)FDA LinkGeneric
06/2011 - 07/2003
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2003
3Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2009
3ApomorphineFDA Link
12/2021 - 05/2003
3TabletsIBA
01/2015 - 07/2010
3entacapone (Comtan)FDA Link
07/2013 - 04/2009
3Dopamine Agents (Dopaminergic Agents)IBA
05/2011 - 07/2006
2mesoglycanIBA
03/2022 - 11/2021
2istradefyllineIBA
01/2021 - 11/2018
2Carboxy-LyasesIBA
01/2021 - 12/2018
2EnzymesIBA
11/2020 - 12/2009
2Antipsychotic Agents (Antipsychotics)IBA
11/2020 - 12/2009
2Adenosine (Adenocard)FDA LinkGeneric
06/2017 - 12/2015
22- (2- furanyl)- 7- (2- (4- (4- (2- methoxyethoxy)phenyl)- 1- piperazinyl)ethyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidine- 5- amineIBA
06/2017 - 12/2015
2mavoglurantIBA
01/2016 - 11/2013
2CabergolineFDA LinkGeneric
06/2015 - 07/2003
2sirioIBA
01/2015 - 07/2010
2levodopa drug combination carbidopa (Nakom)FDA LinkGeneric
12/2014 - 09/2010
2ProdrugsIBA
07/2010 - 01/2007
2DNA (Deoxyribonucleic Acid)IBA
01/2005 - 03/2003
1Glutamic Acid (Glutamate)FDA Link
02/2022
1Hyaluronic Acid (Hyaluronan)IBA
02/2022
1Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2022
1Amyloid beta-PeptidesIBA
01/2022
1Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
01/2021
1BenzodiazepinesIBA
01/2021
1Amyloid (Amyloid Fibrils)IBA
11/2020
1hydroxide ionIBA
09/2020
1CytochromesIBA
09/2020
1BenserazideIBA
03/2020
1Fatty Acids (Saturated Fatty Acids)IBA
01/2020
1amsonic acid (DAS)IBA
05/2019
1Cholinergic Agents (Cholinergics)IBA
01/2019
13-Iodobenzylguanidine (Iobenguane)IBA
12/2018
1Aromatic-L-Amino-Acid DecarboxylasesIBA
12/2018
1TransferasesIBA
10/2018
1catechol (pyrocatechol)IBA
10/2018
1Antidepressive Agents (Antidepressants)IBA
01/2017
1SynucleinsIBA
01/2017
13- (6- p- tolylpyridin- 3- yloxy)- 1- azabicyclo(2.2.2)octaneIBA
01/2016
1Syntex adjuvant formulationIBA
01/2016
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2016
1salicylhydroxamic acid (SHAM)IBA
01/2015
1propylene diquat (PDQ(+))IBA
07/2014
1Amantadine (Aman)FDA LinkGeneric
11/2013

Therapy/Procedure

29Therapeutics
10/2021 - 09/2002
5Activities of Daily Living (ADL)
01/2020 - 03/2010
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
09/2020
1Duration of Therapy
12/2019
1Oral Administration
01/2019
1Sympathectomy (Sympathectomies)
12/2018
1Wearable Electronic Devices
04/2018